Drug-Drug Interactions of Irinotecan, 5-Fluorouracil, Folinic Acid and Oxaliplatin and Its Activity in Colorectal Carcinoma Treatment

The combination of folinic acid, 5-fluorouracil, oxaliplatin and/or irinotecan (FOLFOXIRI) is the standard of care for metastatic colorectal cancer (CRC). This strategy inhibits tumor growth but provokes drug resistance and serious side effects. We aimed to improve FOLFOXIRI by optimization of the d...

Descripción completa

Detalles Bibliográficos
Autores principales: Zoetemelk, Marloes, Ramzy, George M., Rausch, Magdalena, Nowak-Sliwinska, Patrycja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321123/
https://www.ncbi.nlm.nih.gov/pubmed/32512790
http://dx.doi.org/10.3390/molecules25112614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321123/
https://www.ncbi.nlm.nih.gov/pubmed/32512790
http://dx.doi.org/10.3390/molecules25112614

Ejemplares similares